Isolation, growth, differentiation and genetic engineering of human muscle cells
CA 2116118 A1 · Owner: The Board Of Trustees Of The Leland Stanford Junior University · Inventors: Hughes, Simon M.; Blau, Helen M.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Myoblasts are produced conveniently in low or serum-free medium for use in introduction into a mammalian host particularly a, human host, for treatment of diseases of muscle tissue or acting as carriers for genetic capabilities, particularly correcting a genetic defect or for production of a soluble protein which may, serve in a therapy for the mammalian host. Myoblasts introduced into tissue are able to migrate to sites distal from the site of injection, expanding the area of their effect.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed August 19, 1992. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended August 19, 2012.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by August 19, 2014.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.